A mechanistic multi-centre, parallel group, randomised placebo controlled trial of Mesalazine for treatment of irritable bowel syndrome with diarrhoea (IBS-D)
- Submitting institution
-
University of Nottingham, The
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1329171
- Type
- D - Journal article
- DOI
-
10.1136/gutjnl-2015-309122
- Title of journal
- Gut
- Article number
- -
- First page
- 91
- Volume
- 65
- Issue
- 1
- ISSN
- 0017-5749
- Open access status
- Out of scope for open access requirements
- Month of publication
- March
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
12
- Research group(s)
-
G - Nottingham Digestive Diseases Centre
- Citation count
- 37
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
